跳至主要内容
临床试验/NCT01593579
NCT01593579撤回不适用

Autonomic Phenotype Before and After Akt Inhibition: Akt Therapy for Melanoma Sub-study

Vanderbilt University1 个研究点 分布在 1 个国家开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Drop in systolic blood pressure before and after Akt treatment

研究概览

简要总结

Some Akt inhibitors have produced functional cardiovascular effects such as marked hypotension that may limit their clinical benefit. There are no current data on whether this autonomic failure presents in humans at clinically used doses. We will test the hypothesis that Akt inhibition causes an acute decrease in sympathetic tone and lowers blood pressure.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with melanoma with a BRAF mutation and relapse following therapy with a BRAF inhibitor
  • Enrolled in a clinical trial through the Vanderbilt Ingram Cancer Center (VICC) including an arm with an oral Akt inhibitor
  • Able and willing to provide informed consent

排除标准

  • Factors which in the investigator's opinion would prevent the participant from completing the protocol, including poor compliance during previous studies or an unpredictable schedule
  • Unable to give informed consent

结局指标

主要结局

Drop in systolic blood pressure before and after Akt treatment

时间窗: 8 hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Satish R. Raj

Assistant Professor

Vanderbilt University

研究点 (1)

Loading locations...

相似试验

Autonomic Phenotype Before and After Akt Inhibition | 临床试验